Park Avenue Securities’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Buy
46,609
+3,239
+7% +$673K 0.07% 222
2026
Q1
$9.16M Sell
43,370
-3,335
-7% -$718K 0.07% 211
2025
Q4
$9.6M Buy
46,705
+1,763
+4% +$332K 0.08% 194
2025
Q3
$7.05M Sell
44,942
-159
-0.4% -$24.6K 0.06% 251
2025
Q2
$7.58M Buy
45,101
+2,646
+6% +$393K 0.07% 203
2025
Q1
$5.85M Buy
42,455
+18,029
+74% +$2.3M 0.07% 179
2024
Q4
$2.89M Buy
24,426
+3,643
+18% +$425K 0.03% 356
2024
Q3
$2.3M Buy
20,783
+3,126
+18% +$327K 0.03% 396
2024
Q2
$1.74M Buy
17,657
+11,082
+169% +$1.13M 0.02% 458
2024
Q1
$736K Buy
6,575
+918
+16% +$99K 0.01% 801
2023
Q4
$570K Buy
+5,657
New +$561K 0.01% 853
2022
Q4
Sell
-3,513
Closed -$234K 1193
2022
Q3
$234K Buy
+3,513
New +$223K ﹤0.01% 1009
2020
Q2
Sell
-7,413
Closed -$355K 687
2020
Q1
$355K Buy
+7,413
New +$385K 0.03% 218
2016
Q1
Sell
-2,363
Closed -$211K 76
2015
Q4
$211K Buy
+2,363
New +$201K 0.04% 58

Other funds holding CAH

Park Avenue Securities's CAH Position: Q2 2026 in Review

Park Avenue Securities increased its Cardinal Health (CAH) stake by 7.5% in Q2 2026, buying an estimated $673K and bringing the position to 46,609 shares worth $11.1M. The position accounts for 0.07% of the portfolio, ranked #222.

Park Avenue Securities first reported a position in CAH in Q4 2015 and has held it in 14 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Park Avenue Securities held 46,609 shares of Cardinal Health worth $11.1M as of Q2 2026.
  • Park Avenue Securities bought 3,239 Cardinal Health shares in Q2 2026, an estimated $673K.
  • Cardinal Health made up 0.07% of Park Avenue Securities's portfolio in Q2 2026, its #222 holding.
  • Park Avenue Securities first reported a position in Cardinal Health in Q4 2015 and has held it in 14 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.